ESR1 and breast carcinoma: We found that these ER-negative breast cancer cells exhibited a biphasic growth response curve to antiestrogens ICI 182, 780 and 4-OHT; antiestrogens stimulated cell proliferation at sub-nM range while inhibited cell growth at μM range.